| Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis A DeCensi, M Puntoni, P Goodwin, M Cazzaniga, A Gennari, B Bonanni, ... Cancer prevention research 3 (11), 1451-1461, 2010 | 1052 | 2010 |
| Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial F Boccardo, A Rubagotti, M Puntoni, P Guglielmini, D Amoroso, A Fini, ... Journal of Clinical Oncology 23 (22), 5138-5147, 2005 | 569 | 2005 |
| HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials A Gennari, MP Sormani, P Pronzato, M Puntoni, M Colozza, U Pfeffer, ... JNCI: Journal of the National Cancer Institute 100 (1), 14-20, 2008 | 504 | 2008 |
| Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders S Gandini, M Puntoni, BM Heckman-Stoddard, BK Dunn, L Ford, ... Cancer prevention research 7 (9), 867-885, 2014 | 486 | 2014 |
| Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial B Bonanni, M Puntoni, M Cazzaniga, G Pruneri, D Serrano, ... Journal of clinical oncology 30 (21), 2593-2600, 2012 | 307 | 2012 |
| Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trials A Gennari, M Stockler, M Puntoni, M Sormani, O Nanni, D Amadori, ... Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2011 | 263 | 2011 |
| HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance: clinical study E Verri, P Guglielmini, M Puntoni, L Perdelli, A Papadia, P Lorenzi, ... Oncology 68 (2-3), 154-161, 2005 | 220 | 2005 |
| Randomized placebo controlled trial of low-dose tamoxifen to prevent local and contralateral recurrence in breast intraepithelial neoplasia A DeCensi, M Puntoni, A Guerrieri-Gonzaga, S Caviglia, F Avino, ... Journal of Clinical Oncology 37 (19), 1629-1637, 2019 | 178 | 2019 |
| Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review AMG Brunasso, M Puntoni, A Gulia, C Massone Rheumatology 50 (9), 1700-1711, 2011 | 173 | 2011 |
| Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study AMG Brunasso, M Puntoni, W Aberer, C Delfino, L Fancelli, C Massone British Journal of Dermatology 168 (6), 1243-1251, 2013 | 152 | 2013 |
| PI3K/AKT/mTOR pathway in ovarian cancer treatment: are we on the right track? ML Gasparri, E Bardhi, I Ruscito, A Papadia, AA Farooqi, C Marchetti, ... Geburtshilfe und Frauenheilkunde 77 (10), 1095-1103, 2017 | 144 | 2017 |
| Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study A Piccardo, E Lopci, M Conte, A Garaventa, L Foppiani, V Altrinetti, ... European journal of nuclear medicine and molecular imaging 39, 57-71, 2012 | 131 | 2012 |
| Prognostic factors for post-COVID-19 syndrome: a systematic review and meta-analysis G Maglietta, F Diodati, M Puntoni, S Lazzarelli, B Marcomini, L Patrizi, ... Journal of clinical medicine 11 (6), 1541, 2022 | 130 | 2022 |
| Clinical trials with retinoids for breast cancer chemoprevention S Zanardi, D Serrano, A Argusti, M Barile, M Puntoni, A Decensi Endocrine-related cancer 13 (1), 51-68, 2006 | 125 | 2006 |
| Focus on high-risk DTC patients: high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and … A Piccardo, F Arecco, M Puntoni, L Foppiani, M Cabria, S Corvisieri, ... Clinical nuclear medicine 38 (1), 18-24, 2013 | 119 | 2013 |
| Sleep quality among police officers: implications and insights from a systematic review and meta-analysis of the literature S Garbarino, O Guglielmi, M Puntoni, NL Bragazzi, N Magnavita International journal of environmental research and public health 16 (5), 885, 2019 | 114 | 2019 |
| Estrogen receptor-β affects the prognosis of human malignant mesothelioma G Pinton, E Brunelli, B Murer, R Puntoni, M Puntoni, DA Fennell, ... Cancer research 69 (11), 4598-4604, 2009 | 105 | 2009 |
| The effect of metformin on apoptosis in a breast cancer presurgical trial M Cazzaniga, A DeCensi, G Pruneri, M Puntoni, L Bottiglieri, C Varricchio, ... British journal of cancer 109 (11), 2792-2797, 2013 | 95 | 2013 |
| Brachial plexus MR imaging: accuracy and reproducibility of DTI-derived measurements and fibre tractography at 3.0-T A Tagliafico, M Calabrese, M Puntoni, D Pace, G Baio, CE Neumaier, ... European radiology 21, 1764-1771, 2011 | 90 | 2011 |
| Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial A DeCensi, M Puntoni, S Gandini, A Guerrieri-Gonzaga, HA Johansson, ... Breast cancer research and treatment 148, 81-90, 2014 | 88 | 2014 |
